Clinical Trial Update: Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating deprescribing beta-blockers in elderly patients with heart failure with preserved ejection fraction (HFpEF). Enrollment is b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Beta blockers (class) (beta-adrenergic blockers)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Heart Failure, HFpEF | Phase 4 | Status: ENROLLING_BY_INVITATION